SI21745A - Polimorfi derivata 1-pirol-1-heptanojske kisline, intermediata za pripravo atorvastatina - Google Patents
Polimorfi derivata 1-pirol-1-heptanojske kisline, intermediata za pripravo atorvastatina Download PDFInfo
- Publication number
- SI21745A SI21745A SI200400112A SI200400112A SI21745A SI 21745 A SI21745 A SI 21745A SI 200400112 A SI200400112 A SI 200400112A SI 200400112 A SI200400112 A SI 200400112A SI 21745 A SI21745 A SI 21745A
- Authority
- SI
- Slovenia
- Prior art keywords
- phenyl
- methylethyl
- butyl ester
- tertiary butyl
- dihydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pyrrole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Priority Applications (17)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200400112A SI21745A (sl) | 2004-04-09 | 2004-04-09 | Polimorfi derivata 1-pirol-1-heptanojske kisline, intermediata za pripravo atorvastatina |
PL05729986T PL1732886T3 (pl) | 2004-04-09 | 2005-04-08 | Odmiany polimorficzne estru tert.-butylowego atorwastatyny i ich zastosowanie jako związków pośrednich do wytwarzania atorwastatyny |
DK05729986.9T DK1732886T3 (da) | 2004-04-09 | 2005-04-08 | Polymorfer af atorvastasin-tert.-butylester og anvendelse som intermediære til fremstilling af atorvastatin |
DE602005019703T DE602005019703D1 (de) | 2004-04-09 | 2005-04-08 | Polymorphe von atorvastatin-tert.-butylester und deren verwendung als zwischenprodukte für die herstellung von atorvastatin |
CN200580012246XA CN1946687B (zh) | 2004-04-09 | 2005-04-08 | 阿托伐他汀叔丁基酯的多晶型物及其作为中间体在制备阿托伐他汀中的应用 |
RSP-2010/0173A RS51259B (sr) | 2004-04-09 | 2005-04-08 | Polimorf atorvastatin tert.-butilestra i korišćenje intermediata za dobijanje atorvastatina |
EP05729986A EP1732886B1 (en) | 2004-04-09 | 2005-04-08 | Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
ES05729986T ES2339570T3 (es) | 2004-04-09 | 2005-04-08 | Polimorfos de ester terc-butilo de la atorvastatina y su utilizacion como intermediarios para la preparacion de la atorvastatina. |
AT05729986T ATE459602T1 (de) | 2004-04-09 | 2005-04-08 | Polymorphe von atorvastatin-tert.-butylester und deren verwendung als zwischenprodukte für die herstellung von atorvastatin |
EA200601651A EA010166B1 (ru) | 2004-04-09 | 2005-04-08 | Полиморфные формы трет-бутилового эфира аторвастатина и их использование в качестве промежуточных соединений для получения аторвастатина |
PT05729986T PT1732886E (pt) | 2004-04-09 | 2005-04-08 | Polimorfos de éster de tert-butilo de atorvastatina e utilização como intermediários para a preparação de atorvastatina |
PCT/EP2005/003733 WO2005097742A1 (en) | 2004-04-09 | 2005-04-08 | Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin |
CN2009101368132A CN101538238B (zh) | 2004-04-09 | 2005-04-08 | 阿托伐他汀叔丁基酯的多晶型物及其作为中间体在制备阿托伐他汀中的应用 |
SI200531002T SI1732886T1 (sl) | 2004-04-09 | 2005-04-08 | Polimorfi terc butil estra atorvastatina in uporaba kot intermediati za pripravo atorvastatina |
UAA200610957A UA86059C2 (ru) | 2004-04-09 | 2005-08-04 | Полиморфные формы трет-бутилового эфира аторвастатина и их использование как промежуточных соединений для получения аторвастатина |
NO20065146A NO20065146L (no) | 2004-04-09 | 2006-11-08 | Polymorfer av atorvastatin tert.-butylester og anvendelse derav som mellomprodukter for fremstilling av atorvastatin |
HR20100217T HRP20100217T1 (hr) | 2004-04-09 | 2010-04-16 | POLIMORFI tert-BUTILNOG ESTERA ATORVASTATINA I NJIHOVA UPOTREBA KAO MEĐUPRODUKATA U DOBIVANJU ATORVASTATINA |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI200400112A SI21745A (sl) | 2004-04-09 | 2004-04-09 | Polimorfi derivata 1-pirol-1-heptanojske kisline, intermediata za pripravo atorvastatina |
Publications (1)
Publication Number | Publication Date |
---|---|
SI21745A true SI21745A (sl) | 2005-10-31 |
Family
ID=34963800
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200400112A SI21745A (sl) | 2004-04-09 | 2004-04-09 | Polimorfi derivata 1-pirol-1-heptanojske kisline, intermediata za pripravo atorvastatina |
SI200531002T SI1732886T1 (sl) | 2004-04-09 | 2005-04-08 | Polimorfi terc butil estra atorvastatina in uporaba kot intermediati za pripravo atorvastatina |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200531002T SI1732886T1 (sl) | 2004-04-09 | 2005-04-08 | Polimorfi terc butil estra atorvastatina in uporaba kot intermediati za pripravo atorvastatina |
Country Status (15)
Country | Link |
---|---|
EP (1) | EP1732886B1 (ru) |
CN (2) | CN1946687B (ru) |
AT (1) | ATE459602T1 (ru) |
DE (1) | DE602005019703D1 (ru) |
DK (1) | DK1732886T3 (ru) |
EA (1) | EA010166B1 (ru) |
ES (1) | ES2339570T3 (ru) |
HR (1) | HRP20100217T1 (ru) |
NO (1) | NO20065146L (ru) |
PL (1) | PL1732886T3 (ru) |
PT (1) | PT1732886E (ru) |
RS (1) | RS51259B (ru) |
SI (2) | SI21745A (ru) |
UA (1) | UA86059C2 (ru) |
WO (1) | WO2005097742A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009514851A (ja) * | 2005-11-08 | 2009-04-09 | ランバクシー ラボラトリーズ リミテッド | (3r,5r)−7−[2−(4−フルオロフェニル)−5−イソプロピル−3−フェニル−4−[(4−ヒドロキシメチルフェニルアミノ)カルボニル]−ピロール−1−イル]−3,5−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法 |
EP2185527A2 (en) * | 2007-07-11 | 2010-05-19 | Actavis Group PTC EHF | Novel polymorph of atorvastatin calcium and use thereof for the preparation of amorphous atorvastatin calcium |
WO2009023260A2 (en) * | 2007-08-15 | 2009-02-19 | Teva Pharmaceutical Industries Ltd. | An improved process for synthesis of pyrrole derivative, an intermediate for atorvastatin |
CN101560177B (zh) * | 2008-04-16 | 2012-10-03 | 北京万全阳光医学技术有限公司 | 一种阿托伐他汀钙的制备方法 |
EP2413911B1 (en) | 2009-03-31 | 2014-02-19 | KRKA, D.D., Novo Mesto | Progressive emulsion crystallization |
CN105693587A (zh) * | 2016-01-15 | 2016-06-22 | 安徽悦康凯悦制药有限公司 | 一种阿托伐他汀钙的生产工艺 |
CN109280024A (zh) * | 2018-10-09 | 2019-01-29 | 河南师范大学 | 一种高纯度阿托伐他汀叔丁酯的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI94339C (fi) * | 1989-07-21 | 1995-08-25 | Warner Lambert Co | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi |
CA2427255A1 (en) * | 2000-11-16 | 2002-06-06 | Teva Pharmaceutical Industries Ltd. | Hydrolysis of [r(r*,r*)]-2-(4-fluorophenyl)-.beta.,.delta. -dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid esters with calcium hydroxide |
US6476235B2 (en) * | 2001-01-09 | 2002-11-05 | Warner-Lambert Company | Process for the synthesis of 5-(4-fluorophenyl)-1-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-2-isopropyl-4-phenyl-1H-pyrrole-3-carboxylic acid phenylamide |
MXPA04001451A (es) * | 2001-08-16 | 2005-02-17 | Teva Pharma | Procesos para preparar formas de sal de calcio de estatinas. |
-
2004
- 2004-04-09 SI SI200400112A patent/SI21745A/sl not_active IP Right Cessation
-
2005
- 2005-04-08 PL PL05729986T patent/PL1732886T3/pl unknown
- 2005-04-08 CN CN200580012246XA patent/CN1946687B/zh not_active Expired - Fee Related
- 2005-04-08 SI SI200531002T patent/SI1732886T1/sl unknown
- 2005-04-08 RS RSP-2010/0173A patent/RS51259B/sr unknown
- 2005-04-08 PT PT05729986T patent/PT1732886E/pt unknown
- 2005-04-08 EP EP05729986A patent/EP1732886B1/en active Active
- 2005-04-08 DE DE602005019703T patent/DE602005019703D1/de active Active
- 2005-04-08 EA EA200601651A patent/EA010166B1/ru not_active IP Right Cessation
- 2005-04-08 AT AT05729986T patent/ATE459602T1/de active
- 2005-04-08 DK DK05729986.9T patent/DK1732886T3/da active
- 2005-04-08 ES ES05729986T patent/ES2339570T3/es active Active
- 2005-04-08 WO PCT/EP2005/003733 patent/WO2005097742A1/en active Application Filing
- 2005-04-08 CN CN2009101368132A patent/CN101538238B/zh not_active Expired - Fee Related
- 2005-08-04 UA UAA200610957A patent/UA86059C2/ru unknown
-
2006
- 2006-11-08 NO NO20065146A patent/NO20065146L/no not_active Application Discontinuation
-
2010
- 2010-04-16 HR HR20100217T patent/HRP20100217T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
SI1732886T1 (sl) | 2010-06-30 |
EA010166B1 (ru) | 2008-06-30 |
CN101538238B (zh) | 2012-08-29 |
DE602005019703D1 (de) | 2010-04-15 |
NO20065146L (no) | 2006-11-08 |
CN101538238A (zh) | 2009-09-23 |
DK1732886T3 (da) | 2010-06-14 |
EP1732886B1 (en) | 2010-03-03 |
CN1946687B (zh) | 2011-09-28 |
ES2339570T3 (es) | 2010-05-21 |
PT1732886E (pt) | 2010-03-12 |
HRP20100217T1 (hr) | 2010-05-31 |
EP1732886A1 (en) | 2006-12-20 |
PL1732886T3 (pl) | 2010-08-31 |
UA86059C2 (ru) | 2009-03-25 |
WO2005097742A1 (en) | 2005-10-20 |
RS51259B (sr) | 2010-12-31 |
EA200601651A1 (ru) | 2007-02-27 |
ATE459602T1 (de) | 2010-03-15 |
CN1946687A (zh) | 2007-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI94339C (fi) | Menetelmä farmaseuttisesti käyttökelpoisen /R-(R*,R*)/-2-(4-fluorifenyyli)- , -dihydroksi-5-(1-metyylietyyli)-3-fenyyli-4-/(fenyyliamino)karbonyyli/-1H-pyrroli-1-heptaanihapon ja sen farmaseuttisesti hyväksyttävien suolojen valmistamiseksi | |
KR100790766B1 (ko) | 아토르바스타틴의 결정 형태, 이의 제조방법 및 이를 포함하는 약제학적 조성물 | |
SK7212003A3 (en) | Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy- 5-(1-methylethyl)-3-fenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1- heptanoic acid esters with calcium hydroxide | |
US20110190369A1 (en) | Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors | |
CZ2004126A3 (cs) | Krystalické formy VI. A VII. vápenaté soli atorvastatinu | |
EP1732886B1 (en) | Polymorphs of atorvastatin tert.-butylester and use as intermediates for the preparation of atorvastatin | |
JP2006503024A (ja) | Vi型アトルバスタチンカルシウムまたはその水和物 | |
WO2007096751A1 (en) | Process for the preparation of atorvastatin calcium | |
US7615647B2 (en) | Process for producing atorvastatin hemicalcium | |
US20090099371A1 (en) | Process for the preparation of amorphous atorvastatin calcium salt | |
US7074818B2 (en) | Crystalline forms VI and VII of Atorvastatin calcium | |
US7361772B2 (en) | Process for the production of atorvastatin calcium | |
GB2424880A (en) | Crystalline forms of atorvastatin sodium, processes for their preparation and their use in inhibiting HMG-CoA reductase | |
JP2010516756A (ja) | アトルバスタチンのストロンチウム塩、及びこれを含む医薬組成物 | |
US20040102511A1 (en) | Substituted pyrrole derivatives | |
US20070149605A1 (en) | Substituted pyrrole derivatives as hmg-coa reductase inhibitors | |
CA2679317A1 (en) | Novel crystal forms of pyrrolylheptanoic acid derivatives | |
WO2010069593A1 (en) | Use of amphiphilic compounds for controlled crystallization of statins and statin intermediates | |
EP2130819A2 (en) | Crystalline forms of atorvastatin magnesium | |
WO2006067795A2 (en) | Novel polymorphic forms of atorvastatin lactone and process for preparing the same | |
WO2006048888A1 (en) | Novel process for the preparation of amorphous atorvastatin calcium salt | |
AU2011211338A1 (en) | Substituted pyrrole derivatives and their use as HMG-CO inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
OO00 | Grant of patent |
Effective date: 20041118 |
|
KO00 | Lapse of patent |
Effective date: 20071207 |